Eli Lilly's experimental gene-editing therapy VERVE-102 shows promise as one-time treatment for high cholesterol

Treatment Imperial patients among first in world to receive pioneering gene-editing treatment for high cholesterol

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol. The drug cleared Thursday ca

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol. The drug cleared Thursday ca

Changing one's genes; children's bleeding disorders; a specific type of high blood pressure: Upstate Medical University's HealthLink on Air for Sunday, Sept. 8, 2019

Medical oncologist Gloria Morris, MD, PhD, and nurse Rachael Grosvenor discuss the gene editing technique known as CRISPR Medical oncologist

Merck's cholesterol pill Lipfendra wins FDA approval

Lipfendra, a new cholesterol pill manufactured by Merck, is used to treat patients with elevated cholesterol levels. The Food and Drug Admin

FDA approves first daily pill to drastically lower cholesterol levels

Federal regulators approved a first-of-its-kind cholesterol medication from Merck that rivals the effectiveness of powerful drugs already on

FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

The drug from Merck was OK'd on Thursday for patients with artery-clogging cholesterol that persists even after taking statins, the standard